A single institutional experience of factors affecting successful identification of sentinel lymph node in breast cancer patients

Surgery

Volumn 146, Issue 4, 2009, Pages 671-677

  Johnson, Matthew T ^a   Guidroz, Julie A ^a   Smith, Brian J ^b   Graham, Michael M ^a   Scott Conner, Carol E H ^a   Sugg, Sonia L ^a   Weigel, Ronald J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BODY MASS; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INSTITUTIONAL REVIEW; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 70349313122     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.06.025     Document Type: Article

References (19)

1. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
2. Krag D.N., Weaver D.L., Alex J.C., and Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2 (1993) 335-339
3. Giuliano A.E., Jones R.C., Brennan M., and Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15 (1997) 2345-2350
4. Goyal A., Newcombe R.G., Mansel R.E., et al. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer 41 (2005) 238-243
5. Goyal A., Newcombe R.G., Chhabra A., and Mansel R.E. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res Treat 99 (2006) 203-208
6. Kern K.A. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 189 (1999) 539-545
7. Wang L., Yu J.M., Wang Y.S., et al. Preoperative lymphoscintigraphy predicts the successful identification but is not necessary in sentinel lymph nodes biopsy in breast cancer. Ann Surg Oncol 14 (2007) 2215-2220
8. Ogasawara Y., Yoshitomi S., Sato S., and Doihara H. Clinical significance of preoperative lymphoscintigraphy for sentinel lymph node biopsy in breast cancer. J Surg Res 148 (2008) 191-196
9. Soran A., Falk J., Bonaventura M., Keenan D., Ahrendt G., and Johnson R. Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity?. J Am Coll Surg 205 (2007) 66-71
10. Marchal F., Rauch P., Morel O., et al. Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes. World J Surg 30 (2006) 55-62
11. Rousseau C., Classe J.M., Campion L., et al. The impact of nonvisualization of sentinel nodes on lymphoscintigraphy in breast cancer. Ann Surg Oncol 12 (2005) 533-538
12. Chakera A.H., Friis E., Hesse U., Al-Suliman N., Zerahn B., and Hesse B. Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 32 (2005) 286-293
13. Shoher A., Diwan A., Teh B.S., Lu H.H., Fisher R., and Lucci Jr. A. Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast cancer. Current Surgery 63 (2006) 207-212
14. Leikola J.P., Leppanen E.A., von Smitten K.A., and Leidenius M.H. Adjusting the radioisotope tracer dose according to the body mass index does not enhance the visualization of axillary sentinel lymph nodes. Acta Radiol 47 (2006) 646-649
15. Lerman H., Lievshitz G., Zak O., Metser U., Schneebaum S., and Even-Sapir E. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med 48 (2007) 201-206
16. Derossis A.M., Fey J., Yeung H., et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 193 (2001) 473-478
17. Bass S.S., Cox C.E., Ku N.N., Berman C., and Reintgen D.S. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 189 (1999) 183-194
18. Wu C.T., Morita E.T., Treseler P.A., et al. Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients. Breast J 9 (2003) 86-90
19. Cserni G., Rajtar M., Boross G., Sinko M., Svebis M., and Baltas B. Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer. World J Surg 26 (2002) 592-597